Elabscience
SKU:E-EL-H2395
Human GAD1(Glutamate Decarboxylase 1) ELISA Kit
Human GAD1(Glutamate Decarboxylase 1) ELISA Kit
Couldn't load pickup availability
The HUMAN GAD1 (Glutamate Decarboxylase 1) ELISA Kit is a cutting-edge diagnostic tool designed for the accurate and efficient measurement of GAD1 levels in human samples. Glutamate Decarboxylase 1 is an enzyme that plays a crucial role in the synthesis of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. This ELISA kit utilizes a highly specific and sensitive antibody-based detection system to quantify GAD1 levels, providing researchers and clinicians with valuable insights into neurological disorders such as epilepsy, schizophrenia, and autoimmune diseases like type 1 diabetes.
The HUMAN GAD1 ELISA Kit offers exceptional performance and reliability, ensuring precise and reproducible results. The kit includes all the necessary components, including pre-coated microplates, standards, controls, and reagents, allowing for a streamlined and user-friendly workflow. The assay is based on the principle of a sandwich enzyme immunoassay, where GAD1 present in the sample is captured by a specific antibody immobilized on the microplate wells. After a series of washing steps to remove any unbound substances, a detection antibody conjugated to an enzyme is added, followed by the addition of a substrate solution. The intensity of the color developed is directly proportional to the amount of GAD1 present in the sample, which can be measured using a microplate reader.
With its high sensitivity and specificity, the HUMAN GAD1 ELISA Kit is an indispensable tool for researchers and clinicians working in the field of neuroscience and autoimmune diseases. Its ability to accurately quantify GAD1 levels in human samples opens up new avenues for understanding the pathogenesis of various disorders and developing targeted therapeutic interventions. Trust in the HUMAN GAD1 ELISA Kit to provide you with reliable and precise results, enabling you to advance your research and improve patient care.
Share
